搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Psychology Today
1 天
How Perfectionism Is Associated with Cyclothymic Disorder
Cyclothymia often goes unnoticed because it's less severe than bipolar disorder, but the decisions associated with it may ...
bpHope
2 天
How to Spot Bipolar ‘Red Flags’ — and What to Do About Them
As a friend of someone living with bipolar disorder, you can offer valuable support by staying alert to the signs of both ...
bpHope
3 天
How Menopause Can Impact Bipolar Disorder Symptoms — and What to Do
For women with bipolar, menopause can bring extra challenges. Here’s what to know and how to manage both during this life ...
5 天
11 Top Myths About Bipolar Disorder, Busted
Discover the truth behind 11 common bipolar disorder myths. Learn the facts to better understand this complex condition and ...
Baylor College of Medicine
10 天
Baylor receives grant to study DBS of treatment-resistant bipolar depression
Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments ...
verywellhealth
12 天
Understanding Bipolar Disorder and Memory Problems
Bipolar disorder has potential links to memory changes during and after depressive or manic episodes. Learn how states and ...
Yahoo Finance
4 天
Alto hits new low as depression drug flunks key test
Alto plans to analyze all the data from the study to “determine the most appropriate next steps, if any,” for ALTO-100 in ...
The American Journal of Managed Care
10 天
Misdiagnosis of Bipolar Disorder and the Impact on Patient Treatment
Bipolar disorder is commonly misdiagnosed depending on the features that present, explained Stephanie Hsia, PharmD, MAEd, ...
Sierra Sun Times
8 天
Yale School of Medicine: Bipolar Disorder Patients Respond to Ketamine, Esketamine Treatment
The U.S. Food and Drug Administration in 2019 approved intranasal esketamine to treat depression in adults. However, little data is available on the use of ketamine or esketamine to treat bipolar ...
biopharma-reporter
3 天
Alto Neuroscience’s depression drug trial fails at phase 2
The negative trial results have tanked the California-based biotech’s market value, with a 70% reduction in share price over ...
4 天
on MSN
Alto Neuroscience stock crashes amid failed study and Wedbush downgrade
Alto Neuroscience (ANRO) shares plunged 66% Wednesday, the day after the company announced its psychiatric drug ALTO-100 had ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈